SENP1 and osteosarcoma: One study aims at determining the ability of a novel SENP1 inhibitor, senpPNA-R8, to silence SENP1 expression and penetrate into organotypic osteosarcoma cultures prepared from freshly collected patient samples (NCT03798587).